Accelerated Aging in Down Syndrome Brain: Neurodegeneration and Astrogliosis Biomarkers

Research demonstrates that individuals with Down syndrome show accelerated neurodegeneration markers in blood plasma, including elevated levels of UCH-L1 and neurofilament light chain, along with indicators of glial cell activation. Mouse models of Down syndrome confirm heightened neuronal cell death, suggesting biological mechanisms underlying accelerated brain aging in this population.